Consumer Health

Uganda’s economy saw real GDP growth of 5% in 2023 and this provided a boost to sales of some consumer health products. Self-medication is driving growth in consumer health in Uganda as consumers are finding it easier and cheaper to purchase…

The picture is fairly positive in 2023, with constant value sales expected to rise slightly and inflationary pressure easing. However, rising prices are still an issue and the overall economy is expected to register a slowdown in growth.

Consumer health in 2023 is exhibiting solid current value growth as the impact of the COVID-19 pandemic diminishes. With the resurgence of seasonal ailments, categories such as cough, cold and allergy (hay fever) remedies and analgesics are…

In 2024, overall consumer health in Vietnam is set to see solid retail current value growth, with positive performances expected in both retail volume and current value terms across most categories, in line with the gradual recovery of the economy in…

While coughs, colds and the flu were less prevalent during the home seclusion of 2020, negatively impacting sales of cough and cold remedies in this year, they returned in full in the 2022/2023 winter season, with society fully reopened, boosting…

In mid-March 2021, Euromonitor International published revised Q1 forecasts for consumer health in the context of a slightly more positive macroeconomic outlook. The implications of this revision are expected to be muted for consumer health, as it is…

Expectations for the global consumer health industry have improved slightly for Q2 2021. Improved macroeconomic forecasts due to widening vaccination rates in markets such as the US will benefit consumer health, especially as consumers emerge from…

In the upcoming years, consumers and businesses face an array of challenges, with income inequality, mass migration and rising uncertainty about another crisis being among the major ones. Nevertheless, within this lie untapped opportunities. This…

The habit of self-medication continues to fuel healthy growth in cough, cold, and allergy (hay fever) remedies in Algeria in 2024. As a result, the outlook for the category remains positive, with most product segments experiencing consistent…

Cough, cold and allergy (hay fever) remedies in Argentina face a sizeable decline in constant value sales over 2024. Average income levels remain below historical standards with many Argentinean households facing reduced purchasing power in the face…

Australia has been impacted by an extended season of colds and flu in 2023, with many Australians becoming ill. As the lockdowns and COVID-19 restrictions were lifted, people no longer followed social distancing, and fewer Australians have been…

Cough, cold and allergy (hay fever) remedies received a strong sales boost in 2022 due to consumers returning to working in the office more frequently again and kids returning to in-school classes. This led to consumers spending more time among other…

Cough, cold and allergy (hay fever) remedies is growing at a moderate pace in current value terms in 2024. Sales rose sharply during the pandemic as some consumers turned to these products to treat mild symptoms of COVID-19. With the pandemic coming…

Overall, cough, cold and allergy (hay fever) remedies in Belgium is quite stable in retail current value terms, with a slight increase projected over 2024. This performance is supported by price rises as many categories are predicted to see dips in…

Seasonal flus have returned, as people mix together once again , post pandemic, and cough, cold and allergy (hay fever remedies) are expected to register moderate current value growth, though constant value growth will be minimal, as rising costs hit…

Cough, cold and allergy (hay fever) continues to rebound following the declines during the COVID-19 pandemic and the slow recovery in its aftermath. Unit prices have been driven up by inflation resulting in double-digit current value growth in 2023,…

In 2023, cough, cold and allergy (hay fever) remedies is set to maintain dynamic current value growth in Brazil. In this year, the conclusion of the Public Health Emergency of International Concern (PHEIC) for COVID-19, as declared by the World…

Price sensitivity among Bulgarian consumers is a key factor influencing their purchasing decisions when it comes to cough, cold, and allergy (hay fever) remedies. As the minimum wage in Bulgaria is just under EUR400 in 2023, a significant portion of…

Locally preferred alternatives, like consuming honey, ginger, and lemon infusions, enjoy widespread popularity among the locals. In households with lower incomes, natural remedies often take precedence as the initial choice before resorting to…

Cough and cold remedies/products are expected to enjoy demand in 2023. However, the shortages of cough and cold medicines, which provided a consistent disruption in 2022, lingered in 2023. Against this background, manufacturers have struggled to keep…